
Terrance Khastgir
Integris Baptist Medical Center,
United States of America
Abstract Title: Management of Congestive Heart Failure - EP Overview
Biography:
Dr. Terrance Khastgir started his journey in medicine in India where he graduated from medical college with distinction and secured 3rd position in the University. He did his residency in Internal medicine from prestigious John’s Hopkins and Sinai Hospital program in Baltimore Maryland. As a resident he participated in research projects and worked under the supervision of Chief of Cardiology. He presented two papers in World Electrophysiology Conference held in Washington DC. He got the best resident award for his outstanding performance as resident. While he was working as a resident he was appointed as Clinical Instructor in Medicine at John’s Hopkins University. He joined University of Oklahoma to peruse his fellowship in cardiovascular medicine and Electrophysiology. During his training he continued to work under the supervision of faculty and published original papers and case reports. Upon graduation he joined Integris Baptist Medical Center which is a tertiary care center in Oklahoma City with robust cardiology services. He actively participated in research projects pertaining to device therapies including Leadless Pacemakers,ICDS BIVICDS ,Subcutaneous ICDS and Cardiac Contractility Modulation devices.He has been presenting his research work in various National and International Cardiology meetings. He has also worked as a consultant for several device companies. Over the years he has developed keen interest in device therapy for various cardiovascular diseases.
Research Interest:
Heart failure is the number one diagnosis for hospital admissions and readmissions. This talk will focus on salient and recent developments in the treatment of heart failure. There is an effort to manage these patients as outpatients with remote monitoring tools. Attendees will take away a message about paradigm shift in management strategies and how it is improving the quality of life and life expectancy for patients with heart failure.